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Available online 9 August 2013Abstract Umbilical cord blood (UCB) is an attractive source of hematopoietic stem cells (HSCs). However, the number of HSCs in
UCB is limited, and attempts to amplify them in vitro remain inefficient. Several publications have documented amplification of
hematopoietic stem/progenitor cells (HSPCs) on endothelial or mesenchymal cells, but the lack of homogeneity in culture conditions
and HSC definition impairs direct comparison of these results. We investigated the ability of different feeder layers, mesenchymal
progenitors (MPs) and endothelial cells (ECs), to amplify hematopoietic stem/progenitor cells. Placental derived HSPCs (defined as
Lin−CD45−/dimCD34+CD38−CD90+) were maintained on confluent feeder layers and the number of cells and their marker expression
were monitored over 21 days. Although both types of feeder layers supported hematopoietic expansion, only endothelial cells
triggered amplification of Lin−CD45−/dimCD34+CD38−CD90+ cells, which peaked at 14 days. The amplified cells differentiated into all
cell lineages, as attested by in vitro colony-forming assays, and were capable of engraftment and multi-lineage differentiation in
sub-lethally irradiated mice. Mesenchymal progenitors promoted amplification of CD38+ cells, previously defined as precursors with
more limited differentiation potential. A competitive assay demonstrated that hematopoietic stem/progenitor cells had a preference
for interacting with endothelial cells in vitro. Cytokine and transcriptomic analysis of both feeder cell types identified differences in
gene expression that correlated with propensity of ECs and MPs to support hematopoietic cell amplification and differentiation
respectively. Finally, we used RNA sequencing of endothelial cells and HSPCs to uncover relevant networks illustrating the complex
interaction between endothelial cells and HSPCs leading to stem/progenitor cell expansion.
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1075Hematopoietic stem/progenitor cell expansion nicheIntroduction
There is an increasing need of HSC transplantation for
treatment of hematological disorders. Bone marrow is the
main source of hematopoietic stem cells (HSCs) (Ballen, 2005;
Broxmeyer et al., 1989, 1990, 1991; Copelan, 2006). However
researchers have investigated other sources of HSCs to
overcome the challenges of finding compatible donors and the
invasiveness of the procedure. Umbilical cord blood derived
HSCs have been extensively investigated and used in the clinical
setting (Tse et al., 2008a, 2008b). However, single cord blood
samples contain insufficient numbers of HSCs to effectively
treat adults requiring bone marrow transplantation (Brunstein
et al., 2007; Majhail et al., 2006).
To overcome these threshold limitations, researchers
have investigated optimal methods for ex vivo HSC amplifi-
cation. Schiedlmeier et al. used the ectopic expression of
HOXB4 to obtain significant HSC expansion (Schiedlmeier et
al., 2007). Several studies have investigated the use of
multiple cytokines to increase HSC numbers in culture
without being able to clearly define the optimal cocktail
(Metcalf, 2008; Zhang and Lodish, 2008). Delaney et al.
amplified HSCs on Jagged 1 coated plates, but the expanded
HSCs failed to achieve long-term engraftment, suggesting
amplification of hematopoietic progenitors (Delaney et al.,
2010).
Recently, investigators have tried to define the HSC niche
in vivo (Levesque et al., 2010) in order to use its signaling
pathways to expand HSCs while maintaining their stemness.
The presence of HSCs in the cord blood suggests that the
placenta and its cellular elements might also contain a niche
for HSCs. Indeed hematopoietic progenitors and long-term
culture-initiating cells have been found in the human
placenta between 8 and 17 weeks of gestation (Barcena et
al., 2009; Chen et al., 2004). Several follow-up studies also
described the role of placenta in amplification of HSCs up to
term (Robin et al., 2009; Serikov et al., 2009; Zhang et al.,
2004).
The close proximity of HSCs to cellular elements in the
placenta and the bone marrow suggests a requirement for
complex signaling networks and has motivated the develop-
ment of cellular based HSC expansion platforms. Many
studies describe the expansion of HSCs on mesenchymal
progenitor (MP) or endothelial cell (EC) feeder layers
(Andrade et al., 2010; Butler et al., 2010; Fei et al., 2007;
Hayashi et al., 2009; Huang et al., 2007; Jang et al., 2006;
Levesque et al., 2010; Li et al., 2006; Mendez-Ferrer et al.,
2010; Robin et al., 2009; Sasaki et al., 2010; Walenda et al.,
2010; Yildirim et al., 2005; Zhang et al., 2004). HUVECs
(human umbilical vein endothelial cells) have been used as a
model for an endothelial niche (Butler et al., 2010; Kobayashi et
al., 2010; Li et al., 2006; Yildirim et al., 2005) while bone
marrow- and placental-derived mesenchymal progenitors
(BM-MPs and PL-MPs) have been used as a surrogate for a
mesenchymal niche (Andrade et al., 2010; Hayashi et al., 2009;
Macmillan et al., 2009; Mendez-Ferrer et al., 2010; Resnick et
al., 2010; Walenda et al., 2010). For instance, Robin et al.
demonstrated that placenta derived perivascular stromal cells
expressing CD13, CD29, CD44 and CD105 could support
hematopoiesis in the placenta (Robin et al., 2009). Similarly,
Yildirim et al. published that HUVECs could expand cord blood
CD34+ cells (Yildirim et al., 2005). The hypothesis underlyingthese experiments is that secreted factors and membrane
bound elements of the feeder cells will provide the signaling
cues allowing cell expansion with maintenance of stemness.
However, due to large variations in the cytokines used, a
standardized protocol for the expansion of clinical grade HSCs is
yet to be devised. Furthermore, the use of fetal bovine serum
(FBS) may also modify the effects of components produced or
secreted by the feeder cells themselves, confounding attempts
to identify the key feeder derived factors required for HSC
expansion.
Recently, our group elucidated the role of the endothelium
and secretion of angiocrine factors in the expansion of mouse
and human HSCs (Butler et al., 2010a, 2010b; Kobayashi et al.,
2010). We developed a model of endothelial cells with
autonomous Akt-activation (HUVECs-E4ORF1, referred to as
E4+ECs) that can survive in the absence of FBS and exhibit
secretion of angiocrine factors. We demonstrated that the
E4+EC platform supported the expansion of serially engraftable
HSCs. Similarly, we have isolated and comprehensively charac-
terized mesenchymal progenitors from the placenta which are
also able to survive in serum free conditions (Raynaud et al.,
2012). However, few studies to date have systematically
compared the capacity of endothelial and mesenchymal
progenitors to facilitate the expansion of UCB-derived HSPCs.
Therefore, in this study we compare the abilities of our
previously engineered E4+EC platform and mesenchymal pro-
genitors to support hematopoietic stem/progenitor cell (HSPC)
proliferation in a serum-free environment.Methods
Cord/placental blood collection and fluorescence-
activated cell sorting of HSPCs
Following approval from the Internal Review Board (HMC-IRB
protocol 9109/09, Weill Cornell Medical College, Qatar), cord
blood and placental tissue were collected from donors at the
Women's Hospital at Hamad Medical Corporation immediately
after elective Cesarean section. Exclusion criteriawere absence
of labor, preterm rupture of membrane (chorioamnionitis), and
the presence of known chromosomal abnormalities.
In this study to retrieve the cord blood and placental
hematopoietic stem and progenitor cells (HSPCs), we carefully
aspirated and milked the placenta through the cord after
detachment of the placenta. To obtain sufficient numbers of
HSPCs, two to three cord/placenta samples were pooled for
each experiment. Each experiment was repeated three to six
times, and error bars in figures represent variability in the
analysis of biological replicates.
Mono-nucleated cells were isolated after centrifugation on
Ficoll gradients. CD34+ cells were enriched using magnetic
beads labeled with anti-CD34 monoclonal antibodies (Miltenyi
Biotech, 130-046-702) and separated on an affinity column
following the manufacturer's instructions. Hematopoietic
stem/progenitor cells defined as Lin−CD45dim/−CD34+CD38−
CD90+ (Supplementary Fig. 1), were further purified by
fluorescence-activated cell sorting (FACS). The following
antibodies were used anti-CD34-APC-Cy7 (BD Biosciences,
343514), CD38-PerCP-Cy5.5 (BD Biosciences, 551400), CD90-
AF700 (BD Biosciences, 550402), CD45-AmCyan (BD Biosciences,
1076 C.M. Raynaud et al.339192), and Lin-FITC (BD Biosciences, 340546). The workflow
of the isolation and co-culture is given in Supplementary Fig. 1.
In our study, the antibody anti CD45-AmCyan was used to
sort and define hematopoietic cells. The clone 2D1 from BD
Biosciences used in this publication was previously shown to
recognize CD45RA, CD45RB and CD45RO isoforms of CD45 (Behm
et al., 1992). Therefore our definition of hematopoietic stem
cells might be more restrictive than those previously published
(Majeti et al., 2007; Seita and Weissman, 2010), In recognition
of this, we hereafter refer to populations purified on the basis of
these markers as hematopoietic stem/progenitor cells (HSPCs).E4+ECs and MPs and co-cultures
E4+ECs were obtained as previously described (Seandel et al.,
2008). The model of Akt-activated HUVECs (HUVECs-E4ORF1
(referred here as E4+ECs)) can survive in the absence of FBS and
exhibit increased secretion of angiocrine factors. As previously
published, HUVECs transformed with E4ORF1 have not been
subjected to sub-cloning and form, like their mesenchymal
progenitor counterpart, multi-clonal and heterogeneous prima-
ry cells.
E4+ECs were expanded in M199 supplemented with 20% FBS,
20 μg/ml β-ECGF (Sigma, E1388), 20 U/ml heparin (Sigma,
H4784), and 1% penicillin/streptomycin (Thermo Scientific,
SV30079.01).A B C
D
Figure 1 CD34+CD31− localize in close proximity of the endothelium
cross-section. HSCs were defined by double staining CD34+CD31− (green
Transversal imaging of a placental vessel. HSCs are defined as CD34+CD
(yellow arrows). P. Large non vascular areas containing placental mesenPL-MPs were isolated from placenta and characterized as
described previously (Raynaud et al., 2012). Cells were
cultured in MP media: DMEM low glucose with 20% FBS, 2 mM
L-glutamine, and 1% penicillin/streptomycin (Barlow et al.,
2008).
Bone marrow mesenchymal progenitors (BMS) were pur-
chased from StemCells Inc. (#MSC-001F, StemCells Inc.) and
cultured in the same conditions as PL-MPs.
24 h prior to co-culture with HSPCs, E4+ECs and MPs were
seeded at 90% confluence on 24 well plates in HSPC culture
media: X-VIVO media (Lonza, 04-418Q) supplemented with
50 ng/ml rhSCF (PeproTech, 300-07), 20 ng/ml rhTPO
(PeproTech, 300-18), 50 ng/ml rhFlt3 (PeproTech, 300-19),
and 1% penicillin/streptomycin (hereafter referred to as STF
media). Media were changed just before sorted hematopoi-
etic cells were seeded on feeders. A total of 10,000 Lin−
CD45dim/−CD34+CD38−CD90+ were directly sorted onto the
feeder layer in STF media (described below). All co-culture
experiments were done in similar media regardless of the
feeder layer.Ex vivo expansion of HSPCs
Hematopoietic cells, either alone or on a feeder layer, were
expanded in STF media. Half of the media were changed
every day for the subsequent 21 days. We analyzed the cellE F G
H
in the placenta. A–H: Confocal microscopy imaging of placental
arrows) CD34-FITC, CD31-PE, CD73-APC and DAPI were used. I–P:
31− (green arrows) and endothelial cells are defined as CD34+CD31+
chymal progenitors defined as CD73+ (*).
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1077Hematopoietic stem/progenitor cell expansion nichepopulation every 7 days by polyvariate flow cytometry to
determine the total number of hematopoietic cells and their
specific marker expression. Feeders were changed every
7 days as follows: Lin+ cells were depleted using a magnetic
bead-based Lin depletion kit (Miltenyi Biotech, 130-092-211).
The remaining negative fraction was seeded on a fresh
monolayer of E4+ECs or MPs as previously described or without
a feeder layer as a negative control (Supplementary Fig. 1).
Conditioned media
To prepare conditioned media, E4+ECs were plated as per
co-culture method previously described with STF media.
Daily, half of the media conditioned by E4+ECs were
collected and centrifuged at 1500 rpm for 5 min to eliminate
cell debris and then passed through a 0.2 μm filter before
being used. These conditioned media were used to replace
half of the media in hematopoietic cell cultures on a daily
basis.
CD34 enrichment and Lin depletion
CD34 positive selection before sorting and Lin depletion
were performed using, respectively, the CD34 MicroBead Kit
(Miltenyi Biotech, 130-046-702) and the Lineage Cell
Depletion Kit (Miltenyi Biotech, 130-092-211), according to
the manufacturer's instructions. Briefly, cells were washed
in X-VIVO media and re-suspended at 108 cells per 300 μl,
and then mixed with 100 μl per 300 μl of FcR Blocking
Reagent (Miltenyi Biotech, 130-059-901) and 100 μl of CD34/Lin beads per 108 cells. Samples were then incubated for
30 min at 4 °C. After washing, magnetic separation was
performed on LS columns (Miltenyi Biotech, 130-042-401).
In vivo transplantation
All mice experiments were approved by the Weill Cornell
Medical College Institutional Review Board. Eight week old
NOD.Cg-PrkdcscidIl2rgtm1Wjl/SzJ (NSG)mice were sublethally
irradiated (250-rads) and transplanted with 1 × 105 CD34+ ex
vivo expanded human cord blood cells. Engraftment was
assessed at 3-weeks and at 12 weeks by assessing the number
of human CD45+ cells in the peripheral blood. At 12 weeks, the
femurs were removed and the absolute number of human
hematopoietic stem/progenitor cells (HSPCs) and the percent-
age of lineage-specific human cells were determined. Post
engraftment HSPC analyses were performed as previously
published (Butler et al., 2012). The in vivo results are the
average of 3 independent experiments; each experiment was
performed with 5 mice in each cohort.
In situ immuno-fluorescence
Placenta specimen (5 × 5 × 5 mm) were embedded in OCT
(Optimal Cutting Temperature) compound (Sakura, 4583) and
snap-frozen in liquid nitrogen, before storage at −80 °C;
7–8 μm sections were prepared using an AS 620 SME cryotome
(Thermo Shandon) and fixed in acetone. Non-specific sites
were blocked for 30 min with blocking media: PBS supple-
mented with 0.3% bovine serum albumin, 0.5% FBS and FcR
1078 C.M. Raynaud et al.Blocking Reagent. Sections were then incubated with primary
antibodies in blocking media for 1 h, washed twice in
PBS containing 0.5% Tween 20 (Sigma-Aldrich, P5927),
and counterstained with 4′,6-diamidino-2-phenylindole (DAPI).
Primary antibodies were mouse anti-human CD31-PE (BD
Bioscience, 553373), CD34-FITC (BD Bioscience, 345801),
CD73-APC (BD Bioscience, 560847) and VEGFR2-APC (BD Bio-
sciences, 560070). Slides were mounted with the Fluoromount
Kit (Molecular Probes, P36935). Sections were analyzed with a
Zeiss confocal microscope, Laser Scanning Microscope 710 (Carl
Zeiss), and images were analyzed using the Zen 2008 V5,0,0228
software (Carl Zeiss).D
A
Figure 2 Hematopoietic stem/progenitor cell expansion and dif
of placental sorted HSPCs on different feeders. 10,000 sorted ce
feeder. Half of the media are changed every day, Lin depletion is p
B — Chart of flow cytometry analysis of total hematopoietic cells a
analysis of Lin−CD45−/dimCD34+CD38−CD90+ on different feeders
contrast microscopy of colony forming unit (CFU) assays carried
CFU-M, CFU-G and CFU-GM is depicted. E — Charts representing the
and expanded without feeder, on E4+ECs or Pl-MPs. F — Compariso
during the expansion process. G — Dot plot representation of CD3
Pl-MPs or E4+ECs. H — Charts comparing the relative ratio of C
time-points during expansion on different feeders.Immuno-staining and FACS analysis
For flow analysis of cell-surface antigens the antibodies de-
scribed above were used (CD45-AmCyan, Lin-FITC, CD34-
APC-Cy7, CD38-PerCP-Cy5.5, and CD90-AF700). Briefly, 106
mono-nucleated cells were blocked for 30 min on ice in PBS
containing 5% FBS, 1%BSA, and 10% FcR Blocking Reagent. Next,
the cell suspension was incubated with specific antibodies for
45 min on ice. Afterwash in PBS, cells were analyzed by FACS on
a SORP (Special Order Research Products) FACSAria II (BD
Biosciences) as described below. Data were processed using the
FACSDiva 6.3 software (BD Biosciences). Following the technicalC
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B
ferentiation on different feeders. A — Phase contrast imaging
lls are cultured without feeder, on a E4+EC or placental-MP
erformed every 7 days and HSPCs are seeded on a new feeder.
t different time-points. C — Chart representing flow cytometry
during the expansion protocol (N = 6; ** P b 0.01). D — Phase
out on MethoCult for 15 days. HSPC differentiation in CFU-E,
ratio of different CFUs for HSCs after isolation from placenta,
n of the CD34/CD38 profiles for Lin−CD45− hematopoietic cells
4/CD38 profile of Lin−CD45− cells cultured without feeder on
D38+/− of Lin−CD45−CD34+ hematopoietic cells at different
PL-MP feeder E4+ECs feederNo feeder
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1079Hematopoietic stem/progenitor cell expansion nicherecommendation of Perfetto et al., doublets were exclud-
ed by FSC-W × FSC-H and SSC-W × SSC-H analysis, single-
stained channels were used for compensation, and
fluorophore-minus-one (FMO) controls were used for gating.
When possible, a total of 500,000 events were acquired per
sample (Perfetto et al., 2004). Lin−CD45−/dimCD34+CD38−CD90+
cell sorting was performed using the same parameters
used for analysis and a purity mask was applied for sorting.
Analysis of a fraction of sorted cells revealed that the
purity of Lin−CD45−/dimCD34+CD38−CD90+ cells was 99%
(data not shown). eGFP-E4+ECs were also used for cell
sorting experiments to preclude the possibility that
detaching endothelial cells contributed to the analysis of
hematopoietic co-cultures.Colony-forming assay
For colony-forming assays, 104 hematopoietic cells were
cultured in 35 mm dishes containing MethoCult 3434(StemCell Technologies), following the manufacturer's
protocols. Colonies were counted on day 12.Transcriptomic analysis
Following 3 days of culture in STF media, PL-MP and E4+EC
RNA was isolated using TRIzol reagent followed by additional
purification using the RNAeasy extraction kit from Qiagen
(QIAGEN, 74106), with RNA yields that produced satisfac-
tory microarray data. Two quality-control measures were
carried out: (1) spectrophotometric analysis, and (2) size-
fractionation using a microfluidics instrument (Agilent
Technologies, G2938C). Samples of total RNA (200 ng)
were analyzed on Affymetrix GeneChip Human Genome
U133 Plus 2.0 Arrays. Data were analyzed using the Partek
Software (Affymetrix, V6.09.1110-6). Class comparison
between E4+ECs and PL-MPs (three biological replicates of
each) was performed to identify gene-expression changes
with significant expression differences (P b 0.05) and 2-fold
HDay7 Day14 Day21
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1080 C.M. Raynaud et al.increased or decreased expression. Partek Software gene
ontology tools were used to determine enrichment of
functional categories (Dennis et al., 2003). Raw data are
available in ArrayExpress with the accession number
E-MEXP-3725.
RNA sequencing and analysis
Lin−CD45−/dimCD34+CD38−CD90+ cells sorted from cord blood
or after 7 days of culture on E4+EC feeder were submitted to
RNA isolation as previously described. An additional DNase1
(Roche, 04716728001) digestion step was performed to
ensure that samples were not contaminated with genomic
DNA. Duplicates of each sample were performed. Library
preparation and paired end sequencing (50 bp length) were
done at the Weill Cornell Qatar Genomics Core Facility using
Illumina HiSeq 2000 sequencer. Short reads were aligned to
the reference human genome (Hg19) using TopHat (with
bowtie 1) (Trapnell et al., 2009). Gene annotations were
from Ensembl packaged into iGenome (Illumina). Alignments
were processed with easyRNASeq (Delhomme et al., 2012)
using the geneModel method to obtain a count table for each
sequence. Differential expression was analyzed with the
edgeR package after filtering out genes with counts of less
than 10 counts per million (cpm) across all categories
(Robinson et al., 2010). Differential expression was consid-
ered significant at a Benjamin-Hochberg FDR of 0.05.
Ingenuity Pathway Analysis
We used Ingenuity Pathway Analysis software (Ingenuity
Systems) to identify and analyze relevant pathways from the
gene lists obtained from the comparison of E4+ECs and PL-MPs
or RNA sequencing. Networks were constructed by overlaying
the genes in the gene list onto a global molecular networkdeveloped from information contained in the Ingenuity
Knowledge Base using keywords such as “proliferation/differ-
entiation of hematopoietic cells.” Networks of the genes up- or
down-regulated in PL-MPs compared to E4+ECs were then
algorithmically generated based on genes known connectivity.
A network is a graphical representation of the molecular
relationships between genes. In the networks, genes are
represented as nodes, and a biological relationship between
two nodes is represented as a line. All edges are supported by
at least one reference from the literature, from a textbook, or
from canonical information stored in the Ingenuity Knowledge
Base. P values for the enrichment of canonical pathways were
then calculated based on the hypergeometric distribution and
with the right-tailed Fisher's exact t-test for 2 × 2 contingency
tables. To select E4+EC cytokines and membrane up-regulated
genes, compared to PL-MPs, upregulated genes were sorted
according to their sub-cellular localization in ingenuity and a
selection of membrane or extracellular domain genes was
done. We inter-connected genes up/down-regulated in Lin−
CD45−/dimCD34+CD38−CD90+ cells cultured on E4+ECs compared
to Lin−CD45−/dimCD34+CD38−CD90+ cells isolated directly from
the cord blood/placenta with genes upregulated in E4+ECs
compared to PL-MPs. To do so, both lists previously generated
were uploaded in Ingenuity Pathway Analysis software and
direct/indirect relationship was built between those two lists
using Ingenuity Knowledge Base.Results
CD34+CD31− cells localize in close proximity to
endothelial cells in the placenta
The placenta and in particular its stromal cells have been
described as a niche for HSCs (Barcena et al., 2009; Robin et
al., 2009; Sasaki et al., 2010; Serikov et al., 2009; Zhang et
Figure 3 Human CD34+ hematopoietic cells co-cultured with E4+ECs give rise to multi-lineage engraftment. A — Percentage of
engrafted of peripheral blood human CD45+ hematopoietic cells at 3 and 12 weeks post-transplant. B — Total number of engrafted
phenotypically marked human hematopoietic stem and progenitor cells. C — Percentage of terminally differentiated mature cells per
femur. Note that human hematopoietic cells co-cultured with E4+ECs have greater engraftment potential and give rise to a higher
number of multi-lineage human hematopoietic progenitors.
1081Hematopoietic stem/progenitor cell expansion nicheal., 2004). Recent studies in human and mouse models
suggest that endothelial cells (ECs) might play an important
role in the HSC niche (Butler et al., 2012; Butler et al., 2010;
Kobayashi et al., 2010). As the placenta could be a source of
HSCs, we decided to compare whether PL-MPs and/or ECs
constitute a platform for the maintenance and expansion of
human HSPCs. First, we performed confocal analysis of termE
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Figure 4 Effect of a dual niche on HSPC expansion. A–C. Phase c
(eGFP-E4+ECs/Pl-MPs at ratio 1/1), or on eGFP-E4+EC feeder alone (C
clusters. D — Charts representing flow cytometry analysis of total HS
Phase contrast imaging of HSCs cultured on eGFP-E4+EC feeder witho
without cytokine (F). G — Charts representing flow cytometry analys
not with cytokines (N = 6; ** P b 0.01).placenta to attempt to localize hematopoietic progenitors/
stem cells within the placental structure. The placenta is a
highly vascularized structure with CD31+CD34+ ECs distrib-
uted among dense CD73+ MP-rich stromal regions (Supple-
mentary Figs. 2A–G) (Raynaud et al., 2012; Serikov et al.,
2009). We were able to locate CD31−CD34+ cells in close
proximity to ECs (Figs. 1A–H), often within the lumen of the4ORF1-GFP
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1082 C.M. Raynaud et al.vessels or in direct contact with ECs. A close proximity of
the ECs with CD73+ does not allow concluding whether
CD34+CD31− cells interact with ECs or mesenchymal cells.
Often CD34+CD31− are observed between CD34+CD31+ cells
and CD73+ cells. Nevertheless, transverse sections of
the vessels confirmed luminal location of CD34+CD31+ cells
(Figs. 1I–L). No CD34+CD31− could be located within
non-vascular placental areas (Figs. 1M–P).Lin−CD45−/dimCD34+CD38−CD90+ cells expand in
co-culture with endothelial feeder
We compared the abilities of MPs and E4+ECs to sustain Lin−
CD45−/dimCD34+CD38−CD90+ cell expansion. In order to avoid
bias and address the role of the different cell types
comprehensively and for clinical relevance, we used a
serum-deprived system. The viability of neither cell type
(MPs and E4+ECs) was compromised in serum-free X-VIVO
media supplemented with the STF cytokine cocktail (data
not shown). A serum free system is primordial as our goal
was to evaluate the intrinsic capacity of mesenchymal
progenitors compared to ECs to amplify hematopoietic
stem/progenitor cells. We therefore used the previously
established endothelial model E4+ECs (Seandel et al., 2008),
demonstrating the capacity to survive in serum-free media
unlike HUVECs, human placental arterial endothelial cells
(HPAECs), or human placental venous endothelial cells
(HPVECs). Furthermore, maintenance of those primordial
ECs would have required stimulation with additional cyto-
kines and serum complement, resulting in loss of their
angiocrine properties or introduction of co-founding factors.Phase-contrast microscopy and flow cytometry analysis,
performed up to 21 days, demonstrated that sorted Lin−
CD45−/dimCD34+CD38−CD90+ cells do not survive without feeder
over 21 days, whereas a large number of cells persisted on
E4+ECs or MPs; however, while after 21 days of culture, sorted
Lin−CD45−/dimCD34+CD38−CD90+ formed grapes-like colonies on
the E4+EC feeder, they were scattered on the MP feeder
(Fig. 2A).
We quantified the different hematopoietic cell populations
by FACS. The total number of hematopoietic cells (non-feeder
cells) was similar on E4+EC or PL-MP feeders, and was
significantly increased compared to the feeder-free condition
(Fig. 2B); however, only E4+ECs were able to expand and
maintain a Lin−CD45−/dimCD34+CD38−CD90+ cell population
(expansion by 2- and 3.3-fold at days 7 and 14 respectively,
P b 0.05); this number persisted up to day 21 (Fig. 2C). This is
concordant with our previous results demonstrating the ability
of E4+ECs to expand hematopoietic stem/progenitors cells that
give rise to repopulating cells (Butler et al., 2012).
We performed methylcellulose colony-forming assay to
evaluate the differentiation potential of the expanded
hematopoietic cells. Cells amplified on PL-MPs or E4+ECs
were able to form CFU-E, CFU-M, CFU-G, and CFU-GM
(Fig. 2D). Culture on both types of feeder induced more
differentiation toward CFU-M and CFU-G formation than fresh
placental Lin−CD45−/dimCD34+CD38−CD90+ cells. CFU numbers
for each condition are provided in Supplementary Fig. 3.
To understand the dynamics of cell expansion we analyzed
further our total expanded hematopoietic population. Consis-
tent with previous results, we observed that a significant
proportion of the amplified hematopoietic cells were Lin−
CD45−/dimCD34−CD38− (Butler et al., 2012; Robin et al., 2009).
E4+ECs>PL-MPs
PL-MPs>E4+ECs
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Proliferation of hematopoietic cells
Differentiation of hematopoietic cells
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B
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CSF1 2.980
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IL6ST 0.401
TNFRSF11B 7.910
TNFRSF11A 0.020
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Figure 5 Transcriptomic comparison of E4+ECs vs. PL-MPs. A–C — Ingenuity Pathway Analysis (IPA) of differentially expressed membrane and extracellular proteins/cytokines
retrieved from transcriptomic analysis of E4+ECs vs. PL-MPs, involved in: hematopoietic cell quantity (A), hematopoietic cell proliferation (B) and hematopoietic cell differentiation (C)
(gene lists provided by IPA software). D — Specific cytokine/protein expression profiles and fold differences between E4+ECs and PL-MPs. E–F — Supervised ingenuity analysis of RNA
sequences differentially expressed between Lin−CD45−/dimCD34+CD38−CD90+ cells either directly issued from cord blood or after 7 days of culture on E4+ECs involved in: proliferation of
hematopoietic progenitor cells (E), quantity of hematopoietic progenitor cells (F). G–H — Interactome between endothelial overexpressed genes compared to PL-MPs and genes over
(G) or under (H) expressed in Lin−CD45−/dimCD34+CD38−CD90+ cells cultured on E4+ECs compared to cells directly isolated from cord/placenta blood. 1083
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1084 C.M. Raynaud et al.While E4+EC feeder amplified the CD34+CD38− population,
most of the cells grown on PL-MPs differentiated into
CD34+CD38+ previously described as progenitors (Seita and
Weissman, 2010) (Figs. 2 F–G). Indeed, after 7 days on PL-MPs
almost 90% of CD34+ cells had acquired the expression of CD38
compared to less than 5% on E4+ECs (Fig. 2H). This difference
remained significant at all-time points indicating the ability of
E4+ECs to sustain Lin−CD45−/dimCD34+CD38−CD90+ phenotype.
We noticed that E4+EC conditioned media were also able to
expand the Lin−CD45−/dimCD34+CD38−CD90+. This is in line
with our previous finding demonstrating the role of
E4+EC-secreted angiocrine factors in the expansion of HSCs
(Kobayashi et al., 2010). (Supplementary Fig. 4).
As our data on the inability of PL-MPs to amplify the
Lin−CD45−/dimCD34+CD38−CD90+ cells are conflicting with
previously published data we controlled for site specific
effect by comparing the effect of PL-MPs to BMS (which
are routinely described). No statistical differences could
be observed between PL-MPs and BMS regarding their
ability to expand the hematopoietic cell populations
(Supplementary Fig. 5).
In vivo engraftment capacities of amplified hemato-
poietic cells
To control the engraftment capacity of amplified hemato-
poietic cells on E4+ECs we evaluated the capacity of the
CD34+ cells amplified on E4+ECs or cultured without feeder
to engraft in sub-lethally irradiated NSG mice. To facilitate
comparison with our previous study, bloods of engrafted NSG
mice were analyzed for expression of CD45, CD34 and AC133
(Butler et al., 2012). 3 and 12 weeks post engraftment,
human CD45+ cells could be detected in the peripheral blood
of mouse injected with CD34+ cells amplified on E4+ECs or
without feeder (Figs. 3A and B). In the femur of engrafted
mice after 12 weeks we were able to detect human HSPCs
(as previously published (Butler et al., 2012)) when CD34+
cells were amplified on E4+ECs or without feeder. Finally wecould illustrate the ability of the HSPCs amplified on E4+ECs
to reconstitute multiple lineages as we could detect both
CD33+ myeloid and CD19+ lymphoid cell lineage (Fig. 3C).
This suggested that E4+ECs amplified CD34+CD38− maintained
their functional abilities. Interestingly the engraftment exper-
imentswere concordantwith the CD34CD38 profile obtained by
in vitro expansion. Indeed In Fig. 2 we illustrated the
persistence without expansion of a CD34+CD38− population in
the cytokine alone (no feeder). To compare with a mesenchy-
mal platform, our preliminary in vitro results demonstrated
that there was no discernible difference between the marker
profiles of hematopoietic cells grown on PL-MP and BMS feeders
(Supplementary Fig. 4). In light of this, we chose to perform
hematopoietic/BMS cell co-culture experiments using serum
freeminimal cytokine conditions prior to engraftment into NSG
mice. However, we observed that hematopoietic progenitor
cells cultured under these conditions did not retain significant
repopulating activity; a result consistent with the loss of
CD34+CD38− on PL-MP and BMS feeders (Fig. 2 and Supplemen-
tary Fig. 4). These findings suggest that culture medium might
be an important contributor to the ability of co-culture
platforms to support the maintenance of hematopoietic cells
with repopulating activity.
A competitive assay confirmed the important role of
E4+ECs over PL-MPs
Because ECs and MPs are in close contact in the placenta, our in
vitro cell-culture conditions might hinder a cooperative effect
of the two cell types. We therefore created a combined MP-EC
feeder and studied its ability to expand hematopoietic cells.
Surprisingly, after seeding, the hematopoietic cells exclusively
located on the E4+ECs (Figs. 3A and B). After a week of culture,
hematopoietic cells expanded within grape-like structures
exclusively in E4+EC-rich areas (Fig. 3C). While the bi-cellular
niche expanded Lin−CD45−/dimCD34+CD38−CD90+ cells more
effectively than the PL-MP feeder alone (~3 fold, P b 0.05), it
was significantly less efficient than the E4+EC feeder alone
GGenes down regulated in Lin-CD45-/dimCD34+CD38-CD90+ cells
cultured on E4+ECs compared to HSPCs directly sorted from placenta
Central components: PIK3R1, ETS1, CXCR4, NFE2L2,
TAB2, ERG, GATA2, HIF1A, NFKBIA, PTK2B, SMAD7,
FOXO1, FYN, IGF1R
Central component: TGFb1, INSR, NOTCH1, EDN1,
SERPINE1, CD40, TNFSF1A, FN1, OCLN, TGFBR2,
TLR4, BRCA1
Extracellular and membrane proteins over-expressed by
E4+ECs compared to PL-MPs
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1085Hematopoietic stem/progenitor cell expansion niche(3.1-fold, P b 0.05). Once again, the presence of PL-MPs
induced differentiation toward CD38+ cells (data not
shown). We next assessed whether the endothelium
might have an effect in the absence of the STF cytokine
cocktail used in our expansion system. E4+ECs alone were
able to maintain the Lin−CD45−/dimCD34+CD38−CD90+ cell
population (Figs. 3E–G), albeit without inducing an
expansion in cell numbers.Distinctive characteristics of the PL-MP and E4+EC
platforms
Our serum-free feeder based model provides a robust tool
for understanding the cellular factors required for expan-
sion of HSPCs. We characterized the cytokine secretion of
both cell types cultured in STF-containing media. We
found that the PL-MPs secreted significantly more GROα
(CXCL1) (~2-fold), IL6 (~8-fold), IL8 (~2-fold), and CCL5
(not detected in E4+EC secretion). E4+ECs secreted more
MCP-1 (CCL2) (~20-fold) and MIF (~1.2-fold) (Supplemen-
tary Fig. 6). Overall, cytokines secreted by MPs include
those implicated in progenitor differentiation (Emadi et
al., 2005), while the cytokines produced by the E4+ECs are
often associated with chemo-attraction (Abangan et al.,
2010).
We also characterized the differences between the two
different feeders by performing whole-genome transcriptomic
analysis. 5142 geneswere differentially expressed between the
two cell types (≥2-fold, FDR N 0.05) (Supplementary Table 1).
We confirmed the cytokine-array data with the transcriptomicdata; CXCL1 (48 fold), IL6 (10 fold), IL8 (200 fold), and CCL5
(275 fold) were overexpressed in PL-MPs compared to E4+ECs.
We next performed Ingenuity Pathway Analysis (IPA) of
the genes differentially expressed between PL-MPs and
E4+ECs, using keywords related to quantity, proliferation,
or differentiation of hematopoietic cells. PL-MPs expressed
more molecules responsible for differentiation of hemato-
poietic cells than E4+ECs (Figs. 3A–C). We also compared the
expression of previously described HSCs amplifying angiocrine
factors (Kobayashi et al., 2010) between the two feeders
(Fig. 4D and Supplementary Table 2). Interestingly while the
PL-MPs expressed amajority of the predicted angiocrine factors
responsible for HSC self-renewal they had very low expression of
Notch ligands (Jagged 1 (9 fold), Jagged 2 (5 fold), and DLL1 (12
fold)), previously described as critical for HSC amplification
(Kobayashi et al., 2010).
RNA sequencing analysis
To monitor the possible modifications triggered by
HSPC amplification on E4+EC feeder, RNA sequencing was
performed on Lin−CD45−/dimCD34+CD38−CD90+ cells either
before or after 7 days of culture on E4+ECs. A PCA
representation of normalized results is shown in Supple-
mentary Fig. 7. This analysis demonstrated differences
between freshly isolated Lin−CD45−/dimCD34+CD38−CD90+
cells and the same population that had been cultured on
E4+ECs. Indeed, 1430 RNA sequences were differentially
expressed between Lin−CD45−/dimCD34+CD38−CD90+ cells
isolated from blood and cultured cells on E4+ECs (Supple-
mentary Table 3).
HGenes down regulated in Lin-CD45-/dimCD34+CD38-CD90+ cells
cultured on E4+ECs compared to HSPCs directly sorted from placenta
Extracellular and membrane proteins over-expressed by
E4+ECs compared to PL-MPs
Central components: MYC, CDK2, CEBPA, BIRC5, MYBL2,
ACTB, GRB2, MMP2, ANXA2
Central component: TGFb1, INSR, EDN1, SERPINE1
CD40, TNFSF1A, TGFBR2, TLR4, KDR, EPB41, NRAS,
COL18A1
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1086 C.M. Raynaud et al.Supervised ingenuity analysis indicated that these 1430
RNA sequences included genes involved in proliferation of
hematopoietic progenitor cells. In particular, three critical
transcription factors are up-regulated in Lin−CD45−/
dimCD34+CD38−CD90+ cell culture on E4+ECs: MYC, CEBPA
and CDK2 (Fig. 4E). Similarly, MYC and CEBPA are central
transcription factors when analyzing genes involved in the
quantity of hematopoietic progenitor cells (Fig. 4F). We
went further and decided to correlate those results with the
previously described genes over expressed in E4+ECs com-
pared to PL-MPs and build the interactome between
endothelial and Lin−CD45−/dimCD34+CD38−CD90+ cells.
Genes overexpressed in E4+ECs localized in the extracellular
space or at the plasma membrane were selected and direct/
indirect correlation was analyzed with up or down-regulated
genes in cells cultured on E4+ECs (Figs. 4G and H). This
complex network aimed to identify central cytokines/
membrane proteins expressed by E4+ECs responsible for
Lin−CD45−CD34+CD38−CD90+ cell amplification. We identi-
fied the following E4+EC upregulated genes TGFB1, INSR,
EDN1, SERPINE1, CD40, TNFSF1A, TGFBR2, TLR4, KDR,
EPB41, NRAS and COL18A1 as central components of the
interactome between E4+ECs and Lin−CD45−/dimCD34+CD38−
CD90+ upregulated genes (Fig. 4G). Similarly the following
E4+EC upregulated genes TGFB1, INSR, NOTCH1, EDN1,
SERPINE1, CD40, TNFSF1A, FN1, OCLN, TGFBR2, TLR4 and
BRCA1 were identified as central components of the
interactome between E4+ECs and Lin−CD45−/dimCD34+CD38−
CD90+ cells downregulated genes (Fig. 4I). Interestingly, the
main most central protein TGFB1 was previously proposed as
a component leading to hibernation of HSCs in the bone
marrow, thus inhibiting differentiation.Lin−CD45−/dimCD34+CD38−CD90+ cells' up-regulated cen-
tral components were MYC, CDK2, CEBPA, BIRC5, MYBL2,
ACTB, GRB2, MMP2 and ANXA2 (Fig. 4G). It is interesting to
find as a major component of the interactome the 3
transcription factors previously described as involved in
proliferation of hematopoietic stem/progenitor cells. Lin−
CD45−/dimCD34+CD38−CD90+ cells' downregulated central
interactome components were PIK3R1, ETS1, CXCR4, NFE2L2,
TAB2, ERG, GATA2, HIF1A, NFKBIA, PTK2B, SMAD7, FOXO1, FYN
and IGF1R (Fig. 4H).Conclusion and discussion
Understanding normal cell–cell interactions and signaling
pathways regulating HSC self-renewal and differentiation
leads to a framework to study the development and expansion
of hematopoietic stem cells. Here we demonstrated that
endothelial cells are able to expand cord blood/placental
CD38− hematopoietic stem/progenitor cells capable of en-
graftment and replenishment of sub-lethally irradiated mice,
while mesenchymal progenitors induce expansion of CD38+
cells.
Many studies described the role of placental MPs in UCB
derived hematopoietic cell expansion. In competition assays
using PL-MP and E4+EC feeders together, we show a clear
preference of hematopoietic cells for interacting with endo-
thelial cells indicating either the role of membrane bound
factors or stronger chemo-attraction by endothelial cells than
PL-MPs. Our transcriptomic analysis demonstrated many
differences between the two feeders. The main difference in
terms of angiocrine factor was the over-expression of Notch
1087Hematopoietic stem/progenitor cell expansion nicheligands by E4+ECs. However transcriptomic and cytokine array
analysis suggested that the observed functional differences are
not based on a single molecule, but most likely rely on the
fine-tuning of factors involved in regulating stemness, expan-
sion, and differentiation. RNA sequencing analysis demonstrat-
ed that cells amplified on E4+EC feeder layers retained
expression of genes involved in ‘cell cycle’, hematopoietic
progenitor cell ‘quantity’ and ‘development’. The broad
interactome we were able to build is concordant with recently
published data on the ability of feeder cells (mesenchymal
progenitors) to expand pancreatic progenitors via a pattern of
signaling cues rather than single genes (Sneddon et al., 2012)
(Fig. 5).
Our bi-cellular niche showed that the ability of ECs to
expand hematopoietic stem/progenitor cells might partially
be linked to cell adhesion and membrane bound signaling.
Indeed, in confocal analysis, CD34+CD31− cells were always
seen in close proximity to the vessels. Hematopoietic cells
formed grape-like colonies on E4+ECs, while they were
scattered on the PL-MPs, suggesting different dynamics of
interaction with the two different types of feeder cells.
Finally, in the competition assay we were surprised to see all
hematopoietic cells adhering to endothelial cells and
expanding on the endothelial network. This suggested that
the placental MPs lacked the appropriate membrane
signaling for chemo-attraction and/or adherence of hema-
topoietic cells.
These observations are concordant with the knowledge of
the HSC niche. For example, it is well described that in the
relationship between the stem cell and their niche ele-
ments, cell to cell position translates into functionality
(Barbier et al., 2012; Vied et al., 2012). Similarly, it is
believed that in the case of neuronal stem cells, asymmetric
division and maintenance of stemness occur close to the
niche (Falcao et al., 2012; Winkler et al., 2010). In mouse
bone marrow (Ding et al., 2012) or in the human placenta
(Serikov et al., 2009), HSCs reside in a perivascular niche
where ECs and perivascular stromal cells play functionally
important roles. Both our cell types express the key niche
component SCF (KIT-LG) indispensable for HSC expansion
(Ding et al., 2012). The role of the endothelium in HSC
expansion has been clearly established by our group and
confirmed by others. Morrison's group not only confirmed the
role of the endothelium as being essential, but also
demonstrated that after knock-out of Nestin+ MPs, HSCs
still expanded in the endothelial niche (Ding et al., 2012).
Consistent with these findings, we could not demonstrate that
placental MPs expanded Lin−CD45−/dimCD34+CD38−CD90+ cells
in our serum-free, reduced cytokine culture conditions.
In this report we directly compared two cell types to provide
a hematopoietic stem/progenitor cell niche in a human system.
Many authors have reported the ability of MSCs to expand the
HSCs or CD34+ cells. However our flow cytometric studies
demonstrated that the majority of the CD34+ cells amplified in
our conditions were actually CD38+ progenitors. We sought to
compare our EC system with a mesenchymal platform that
could be more easily standardized. As such, MPs were cultured
under serum freeminimal cytokine conditions that incorporated
rhSCF, rhTPO and rhFlt3 as growth factors. Unlike previous
reports in which serum containing medium was used (Andrade
et al., 2010; Fei et al., 2007; Hayashi et al., 2009; Huang et al.,
2007; Levesque et al., 2010; Mendez-Ferrer et al., 2010; Robinet al., 2009; Sasaki et al., 2010; Walenda et al., 2010; Zhang et
al., 2004), we found that MPs cultured under our conditions
were unable to support the expansion of hematopoietic cells
with repopulating activity. This result highlights the potentially
critical role of culture conditions in revealing the ability of MPs
to amplify HSPCs.
The transcriptomic comparison of PL-MPs and E4+ECs
showed that MPs express relatively higher levels of cytokines
previously reported as responsible for HSC expansion (such
as ANG1 and IGFBP3), but also higher levels of cytokines
reported to trigger chemo-attraction, differentiation and
mobilization of HSCs (such as CXCL1, IL6, IL8, CCL5, CSF1,
and CXCL12 (Bernad et al., 1994; Ding et al., 2012; Ergen et
al., 2012; Pruijt et al., 2002)). By contrast, ECs expressed
higher levels of factors previously described as essential for
HSC expansion, such as Notch ligands (Jagged 1, Jagged 2,
and DLL1) or DHH from the hedgehog family of transcription
factors (Butler et al., 2010; Delaney et al., 2010; Pajcini et
al., 2011).
We performed RNA sequencing analysis of expanded Lin−
CD45−/dimCD34+CD38−CD90+ cells in comparison to cord blood/
placental Lin−CD45−/dimCD34+CD38−CD90+ cells. In our culture
settings, Lin−CD45−/dimCD34+CD38−CD90+ cells cultured on
E4+ECs up-regulated essential genes for cell cycle regulation:
MYC and CDK2. Iriuchishima et al. described that under hypoxic
conditions HSC quiescence and stemness are MYC dependent
(Iriuchishima et al., 2011). CDK2 has been shown to be a MYC
cofactor leading to the regulation of stemness and self-renewal
(Hydbring and Larsson, 2010). Similarly, CEBPA (1), BIRC5 (2),
MYBL2 (3,4) and GRB2 (5) which were also upregulated in HSPCs
co-cultured with E4+ECs, have been previously demonstrated to
contribute to HSC amplification. We found as central compo-
nents of the interactome, down-regulation of genes
involved in HSC differentiation like: ETS1 (6), NFKBIA (De
Molfetta et al., 2010), IGF1R (14) and PTK2B (7), or
downregulation of NFE2L2 and GATA2 necessary for HSC
amplification (8, 11). Downregulation of these genes in our
E4+EC co-culture system may explain the maintenance of
hematopoietic cells stem/progenitor activity.
By building the interactome between the transcriptomes
of E4+ECs and hematopoietic cells, we identified compo-
nents such as TGFβ1 (over expressed in E4+ECs compared to
PL-MPs) that might be a major factor interacting with genes
upregulated and/or downregulated in hematopoietic cells.
TGFβ1 seems therefore to play a central role in the
hematopoietic cell expansion in our culture settings. The
understanding of the precise mechanism underlying TGFβ1's
central role is beyond the scope of this work. Though, we
can point out the known indirect interaction of TGFβ1 with
up-regulated genes involved in proliferation of hematopoi-
etic cells like BIRC5, CDK2, MYC, CEBPA and PIM1. Similarly,
TGFβ1 interacts with genes down-regulated during the
differentiation of hematopoietic cells like: NFKBIA, FYN,
PTPRC, FOSL1, IRF1 and SOX4. These results raise the
hypothesis that TGFβ1 may play multiple complementary
roles in hematopoietic stem/progenitor cell amplification on
E4+ECs. TGFβ1 may therefore represent a key target to
optimize HSC in vitro amplification.
Future studies should focus on identifying the essential
factors of the endothelial niche responsible for the mainte-
nance and expansion of hematopoietic stem/progenitor cells
and enabling widespread use in clinical applications. A mixed
1088 C.M. Raynaud et al.strategy based on a cellular platform, with fine molecular
targeting strategy, will represent an optimal system for
developing clinically relevant applications.
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